Jaisim Shah

Jaisim Shah has filed trades across 3 companies (mainly through SEC (Form 4)), most often in PDL Biopharma, Inc., Scilex Holding Co and Sorrento Therapeutics, Inc. Over a trading history stretching from 9 January 2006 to 18 December 2024, the count stands at 46 filings.

In open-market terms, that means 10 purchases worth €544k on one side and 15 sales worth €1.1M on the other. On balance, insiders were net sellers of €523k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant and 20 option exercises. Since January 2024: 5 purchases and no sales on the market.

A typical purchase (the median) is worth €28k. Of 7 purchases, 6 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 10 purchases show a median change of -21.5%, with the price up in 40% of them. These figures describe past trades and do not predict future prices.

Most recently, on 18 December 2024, the filings show an open-market purchase worth €13k in Scilex Holding Co. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.